fiel effizient Dort ioannis tarnanas altoida Propeller Greifen Sie zu Aquarium
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
A brain fitbit that can spot Alzheimer's with up to 94% accuracy
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas's email & phone | Altoida's Founder email
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Greek Researcher Receives Top European Innovation Award (video)
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Ioannis Tarnanas - Worldwebforum
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas | Nature Portfolio Health Community